An inhalable version of a single-shot, adenovirus-based viral vector vaccine might provide a new option for COVID-19 vaccination. In October 2021, the World Health Organization set a target for ...

MOSCOW, September 17. /TASS/. A coronavirus vaccine developed by Russia’s State Research Center of Virology and Biotechnology Vector has proved safe during pre-clinical trials and the first ...

have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza ...

Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic, this platform ...

TASS/. The mutations of the novel coronavirus cause only a marginal decrease in the efficacy of vaccines certified in Russia, General Director of the Vector State Research Center of Virology and ...